Tradestie Institutional Equity Comparison Engine

AGZ vs AOK โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AOK Overall Edge

AOK Captures Institutional Edge (1โ€“0 Pillars ยท 1โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to iShares Core 30/70 Conservative Allocation ETF (AOK) driven by superior Momentum & Technical. Fundamentally, AGZ trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus AOK at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, AGZ sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AOK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
AGZ N/M vs AOK N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner AOK
1Y -3.3% vs -0.7% ยท 52W Pos 15% vs 31%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AGZ NYSE Arca
iShares Agency Bond ETF
Institutional Equity
$106.71
+0.0% 1D
Market Cap N/A
1M Return -0.21%
1Y Return -3.33%
Forward P/E N/M
Unified AI Score
42.5 / 100 HOLD
Tech 49.0 Fund 44.0 Flow 50.0 Mom 31.1
AOK NYSE Arca
iShares Core 30/70 Conservative Allocation ETF
Institutional Equity
$40.04
-0.57% 1D
Market Cap N/A
1M Return -1.01%
1Y Return -0.67%
Forward P/E N/M
Unified AI Score
30.0 / 100 SELL
Tech 38.0 Fund 40.0 Flow 50.0 Mom 41.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AGZ -3.33% AOK -0.67% Spread: +2.66 pp (AOK Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AGZ TTM Op. Margin: N/A AOK TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AGZ vs AOK. Trailing 12-month operating profitability (AGZ N/A vs AOK N/A) and valuation multiples (AGZ N/M vs AOK N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AGZ (2) vs AOK (1)
Institutional Metric AGZ AOK Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 15% ($106โ€“$111) 31% ($39โ€“$42) Stronger Trend AOK
Beta / 30D Volatility Risk Regime 0.05ฮฒ ยท 4% Vol 0.41ฮฒ ยท 7% Vol Lower Realized Risk AGZ
Unified Institutional Score Composite Signal 42.5 / 100 (HOLD) 30.0 / 100 (SELL) Higher Composite AGZ

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AGZ vs AOK Buy Guide
AGZ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AGZ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AOK UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AOK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AGZ nor AOK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.